The role of surgery in lung cancer treatment: present indications and future perspectives—state of the art

F Montagne, F Guisier, N Venissac, JM Baste - Cancers, 2021 - mdpi.com
Simple Summary Lung cancer evolutions, innovative systemic treatments, minimally
invasive thoracic surgery approaches and perioperative medical care have changed the role …

The role of lymphadenectomy in early-stage NSCLC

B Manfredini, CC Zirafa, PL Filosso, A Stefani… - Cancers, 2023 - mdpi.com
Simple Summary The extension of lymph node dissection in the treatment of early-stage non-
small cell lung cancer (NSCLC) is currently a controversial argument in the scientific …

Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients

A Bille, KM Woo, U Ahmad, NP Rizk… - European Journal of …, 2017 - academic.oup.com
OBJECTIVES: Early clinical stage (T1 and T2) non-small cell lung cancer (NSCLC) is
commonly treated with anatomic lung resection and lymph node sampling or dissection. The …

[HTML][HTML] Lobe-specific lymph node dissection as a standard procedure in surgery for non–small cell lung cancer: a propensity score matching study

H Adachi, K Sakamaki, T Nishii, T Yamamoto… - Journal of Thoracic …, 2017 - Elsevier
Introduction Systematic lymph node dissection (SND) is the standard procedure in surgical
treatment for NSCLC, but the value of this approach for survival and nodal staging is still …

Efficacy of mediastinal lymph node dissection during lobectomy for lung cancer by thoracoscopy and thoracotomy

TA D'Amico, J Niland, R Mamet, C Zornosa… - The Annals of thoracic …, 2011 - Elsevier
Background Mediastinal lymph node dissection (MLND) is an integral component of
complete resection for non-small cell lung cancer (NSCLC). This study analyzed the …

[HTML][HTML] Lobe-specific nodal dissection for clinical stage I and II NSCLC: Japanese multi-institutional retrospective study using a propensity score analysis

T Hishida, E Miyaoka, K Yokoi, M Tsuboi… - Journal of Thoracic …, 2016 - Elsevier
Objectives The purpose of this study was to assess the surgical outcomes according to the
extent of mediastinal lymph node dissection for patients with NSCLC by using a nationwide …

[HTML][HTML] Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non–small …

F Ishiguro, K Matsuo, T Fukui, S Mori, S Hatooka… - The Journal of thoracic …, 2010 - Elsevier
OBJECTIVE: Lobectomy with systematic complete mediastinal lymph node dissection is
standard surgical treatment for localized non–small cell lung cancer. However, selective …

Rationale for a minimum number of lymph nodes removed with non-small cell lung cancer resection: correlating the number of nodes removed with survival in 98,970 …

AX Samayoa, TA Pezzi, CM Pezzi, E Greer Gay… - Annals of surgical …, 2016 - Springer
Background The benefit of thoracic lymphadenectomy in the treatment of resectable non-
small cell lung cancer (NSCLC) continues to be debated. We hypothesized that the number …

[HTML][HTML] Mediastinal nodal involvement in patients with clinical stage I non–small-cell lung cancer: possibility of rational lymph node dissection

T Haruki, K Aokage, T Miyoshi, T Hishida, G Ishii… - Journal of Thoracic …, 2015 - Elsevier
Background The aim of this study is to elucidate the optimal candidate of selective lymph
node dissection (LND) that reduces the extent of mediastinal LND according to clinical …

Imbalanced data correction based PET/CT radiomics model for predicting lymph node metastasis in clinical stage T1 lung adenocarcinoma

J Lv, X Chen, X Liu, D Du, W Lv, L Lu, H Wu - Frontiers in Oncology, 2022 - frontiersin.org
Objectives To develop and validate the imbalanced data correction based PET/CT radiomics
model for predicting lymph node metastasis (LNM) in clinical stage T1 lung adenocarcinoma …